{{Rsnum
|rsid=10922573
|Gene=GBP2
|Chromosome=1
|position=89122697
|Orientation=plus
|GMAF=0.3393
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=GBP2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 32.3 | 53.8 | 13.8
| HCB | 35.3 | 51.1 | 13.5
| JPT | 48.6 | 43.2 | 8.1
| YRI | 76.0 | 23.3 | 0.7
| ASW | 64.9 | 31.6 | 3.5
| CHB | 35.3 | 51.1 | 13.5
| CHD | 35.6 | 52.9 | 11.5
| GIH | 21.0 | 58.0 | 21.0
| LWK | 85.5 | 14.5 | 0.0
| MEX | 39.7 | 50.0 | 10.3
| MKK | 58.3 | 39.7 | 1.9
| TSI | 44.9 | 44.9 | 10.2
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs10922573
|Name_s=
|Gene_s=GBP2
|Feature=
|Evidence=PubMed ID:17553421; PubMed ID:19118814
|Annotation=This variant is nominally associated with late-onset Alzheimer disease (LOAD) in 2 GWAS studies.
|Drugs=
|Drug Classes=
|Diseases=Alzheimer Disease
|Curation Level=Curated
|PharmGKB Accession ID=PA162363847
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs10922573
|overall_frequency_n=33
|overall_frequency_d=128
|overall_frequency=0.257812
|n_genomes=22
|n_genomes_annotated=0
|n_haplomes=25
|n_articles=0
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}